JVW-1009
JVW-1009 is a Sig2R/PGRMC1 antagonist (Sig1R Ki = 96 nM; Sig2R Ki = 70 nM). JVW-1009 acts as a neuroprotective agent. JVW-1009 can be used in the research of Alzheimer's disease.
For research use only. We do not sell to patients.
- CAS No.: 2089059-30-1
- Formula: C24H24N2
- Molecular Weight:340.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Sigma Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Sigma 1 Receptor 96 nM (Ki) |
Sigma 2 Receptor 70 nM (Ki) |
In Vitro
JVW-1009 binds to purified Sig1R (Ki = 96 nM) and Sig2R (Ki = 70 nM) with approximately equivalent affinity[1].
JVW-1009 (200 μM; 5-day) significantly reduces age-dependent neurodegeneration of VC4 and VC5 cholinergic neurons in SC_APP *Caenorhabditis elegans* via a PGRMC1-mediated pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2089059-30-1
-
Molecular Weight 340.47
-
Formula C24H24N2
-
SMILES
C(N1[C@]2(C=3C([C@@](C2)(CC1)[H])=CC=C(NC4=CC=CC=C4)C3)[H])C5=CC=CC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)